Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1939 1
1947 1
1955 3
1956 1
1958 1
1960 1
1962 1
1963 1
1965 1
1966 4
1967 4
1968 2
1969 3
1970 5
1971 3
1972 2
1973 4
1974 3
1975 23
1976 15
1977 16
1978 14
1979 15
1980 18
1981 30
1982 31
1983 41
1984 40
1985 47
1986 57
1987 40
1988 43
1989 49
1990 55
1991 52
1992 55
1993 53
1994 63
1995 60
1996 65
1997 92
1998 74
1999 91
2000 93
2001 80
2002 85
2003 115
2004 105
2005 121
2006 166
2007 144
2008 145
2009 127
2010 131
2011 156
2012 146
2013 156
2014 165
2015 161
2016 179
2017 168
2018 174
2019 187
2020 218
2021 219
2022 179
2023 159
2024 54

Text availability

Article attribute

Article type

Publication date

Search Results

4,421 results

Results by year

Filters applied: . Clear all
Page 1
Effects of dietary supplements on athletic performance in elite soccer players: a systematic review.
Abreu R, Oliveira CB, Costa JA, Brito J, Teixeira VH. Abreu R, et al. J Int Soc Sports Nutr. 2023 Dec;20(1):2236060. doi: 10.1080/15502783.2023.2236060. J Int Soc Sports Nutr. 2023. PMID: 37462346 Free PMC article. Review.
The studies evaluated the impacts on athletic performance of several dietary supplements, including caffeine, creatine, protein, beverages with carbohydrates and electrolytes, tart cherry juice, nitrate-rich beetroot juice, sodium bicarbonate with minerals, yohimbin …
The studies evaluated the impacts on athletic performance of several dietary supplements, including caffeine, creatine, protein, beverages w …
Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review.
Kamran H, Jneid H, Kayani WT, Virani SS, Levine GN, Nambi V, Khalid U. Kamran H, et al. JAMA. 2021 Apr 20;325(15):1545-1555. doi: 10.1001/jama.2021.0716. JAMA. 2021. PMID: 33877270 Review.
IMPORTANCE: Acute coronary syndrome (ACS) is a major cause of morbidity and mortality in the United States with an annual incidence of approximately 1 million. Dual antiplatelet therapy (DAPT), consisting of aspirin and a P2Y12 inhibitor (clopidogrel, ticagrelor, or prasug …
IMPORTANCE: Acute coronary syndrome (ACS) is a major cause of morbidity and mortality in the United States with an annual incidence of appro …
Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
Subramaniam RM, Suarez-Cuervo C, Wilson RF, Turban S, Zhang A, Sherrod C, Aboagye J, Eng J, Choi MJ, Hutfless S, Bass EB. Subramaniam RM, et al. Ann Intern Med. 2016 Mar 15;164(6):406-16. doi: 10.7326/M15-1456. Epub 2016 Feb 2. Ann Intern Med. 2016. PMID: 26830221 Free article. Review.
BACKGROUND: N-acetylcysteine, sodium bicarbonate, statins, and ascorbic acid have been studied for reducing contrast-induced nephropathy (CIN). ...STUDY SELECTION: Randomized, controlled trials of N-acetylcysteine, sodium bicarbonate, statins, o …
BACKGROUND: N-acetylcysteine, sodium bicarbonate, statins, and ascorbic acid have been studied for reducing contrast-in …
Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.
Zhou Z, Liu C, Yang Y, Wang F, Zhang L, Fu P. Zhou Z, et al. Crit Care. 2023 Jun 7;27(1):222. doi: 10.1186/s13054-023-04519-1. Crit Care. 2023. PMID: 37287084 Free PMC article.
Compared to UFH, RCA was found to be more effective in prolonging filter lifespan (MD 12.0, 95% CI 3.8 to 20.2) and reducing the risk of bleeding. Regional-UFH plus Prostaglandin I2 (Regional-UFH + PGI2) appeared to outperform RCA (MD 37.0, 95% CI 12.0 to 62.0), LMWH (MD 4 …
Compared to UFH, RCA was found to be more effective in prolonging filter lifespan (MD 12.0, 95% CI 3.8 to 20.2) and reducing the risk of ble …
The Future of Aspirin Therapy in Cardiovascular Disease.
Bhatt DL, Pollack CV Jr. Bhatt DL, et al. Am J Cardiol. 2021 Apr 1;144 Suppl 1:S40-S47. doi: 10.1016/j.amjcard.2020.12.019. Am J Cardiol. 2021. PMID: 33706989 Review.
Much has been written about the demise of aspirin (ASA) but reports of its death are premature. The drug remains one of the most widely prescribed by physicians worldwide. ...ASA is an essential member of the duo that makes up dual antiplatelet therapy (a P2Y(12) inhibitor …
Much has been written about the demise of aspirin (ASA) but reports of its death are premature. The drug remains one of the most wide …
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events.
Squizzato A, Bellesini M, Takeda A, Middeldorp S, Donadini MP. Squizzato A, et al. Cochrane Database Syst Rev. 2017 Dec 14;12(12):CD005158. doi: 10.1002/14651858.CD005158.pub4. Cochrane Database Syst Rev. 2017. PMID: 29240976 Free PMC article. Review.
SELECTION CRITERIA: We included all randomised controlled trials comparing over 30 days use of aspirin plus clopidogrel with aspirin plus placebo or aspirin alone in people with coronary disease, ischaemic cerebrovascular disease, peripheral art …
SELECTION CRITERIA: We included all randomised controlled trials comparing over 30 days use of aspirin plus clopidogrel with …
Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition.
Ramacciotti E, Weitz JI. Ramacciotti E, et al. Thromb Res. 2019 Dec;184:44-49. doi: 10.1016/j.thromres.2019.09.033. Epub 2019 Oct 23. Thromb Res. 2019. PMID: 31706067 Review.
This review provides the rationale for dual pathway inhibition with the combination of low-dose rivaroxaban (2.5 mg twice daily) to attenuate thrombin generation and aspirin (100 mg once daily) to reduce platelet activation. Such therapy has been licensed for secondary pre …
This review provides the rationale for dual pathway inhibition with the combination of low-dose rivaroxaban (2.5 mg twice daily) to attenuat …
Vein Graft Patency Rates With Aspirin Plus Clopidogrel Following Coronary Artery Bypass Grafting.
De Bono JA, Conte SM, Florisson DS, Davies RA, Newcomb AE. De Bono JA, et al. Heart Lung Circ. 2020 Jan;29(1):162-163. doi: 10.1016/j.hlc.2019.02.191. Epub 2019 Mar 18. Heart Lung Circ. 2020. PMID: 30929989 Review.
The question addressed was, "In patients who have undergone Coronary Artery Bypass Grafting, does aspirin plus clopidogrel postoperatively improve vein graft patency when compared to aspirin alone?" ...
The question addressed was, "In patients who have undergone Coronary Artery Bypass Grafting, does aspirin plus clopidogrel pos …
Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.
Ma WQ, Zhao Y, Wang Y, Han XQ, Zhu Y, Liu NF. Ma WQ, et al. Int Urol Nephrol. 2018 Jun;50(6):1085-1095. doi: 10.1007/s11255-018-1814-0. Epub 2018 Feb 5. Int Urol Nephrol. 2018. PMID: 29404930 Review.
RESULTS: We identified 3850 records through database searches, of which 107 studies comprising 21,450 participants were finally identified. Compared with intravenous saline, intravenous saline plus pharmacological drugs including statin [relative risk (RR) 0.57; 95% credib …
RESULTS: We identified 3850 records through database searches, of which 107 studies comprising 21,450 participants were finally identified. …
Chinese Herbal Medicine for Aspirin Resistance: A Systematic Review and Meta-Analysis.
Chen H, Shen Z, Chen J, Zhang H, Chen X. Chen H, et al. PLoS One. 2016 May 6;11(5):e0154897. doi: 10.1371/journal.pone.0154897. eCollection 2016. PLoS One. 2016. PMID: 27153119 Free PMC article. Review.
RESULTS: 18 randomized controlled trials (RCTs) involving 1,460 patients were included. 15 RCTs reported significant difference in the reduction of platelet aggregation rate (PAR) induced by adenosine diphosphate (ADP) (P<0.05), and 11 reported significant effect of CHM plu …
RESULTS: 18 randomized controlled trials (RCTs) involving 1,460 patients were included. 15 RCTs reported significant difference in the reduc …
4,421 results